EPZM Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (210)

Latest Posts

About This Stock More About This Stock
Wall Street's Top Weekend Stories, Sunday Dec. 6th
Article By: The Fly
Sunday, January 6, 2019 9:10 PM EDT
Stocks rebounded following a positive jobs report, Powell's comments, and more.
In this article: AZN, GME, MAR, FTNT, IRWD, INTC, NFLX, EPZM
Read
Epizyme Announces Closing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, September 19, 2017 10:19 AM EDT
Epizyme, Inc., today announced the closing of its public offering of 10,557,000 shares of its common stock at a price of $15.25 per share, before underwriting discounts.
In this article: EPZM
Read
Epizyme Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, September 14, 2017 1:24 PM EDT
Epizyme, Inc., today announced the pricing of an underwritten public offering of 9,180,000 shares of its common stock at a price of $15.25 per share, before underwriting discounts.
In this article: EPZM
Read
Biotech Fades After ASCO Abstract Rally
Article By: Rod Raynovich
Friday, May 26, 2017 6:29 PM EDT
Biotechs faded today now that the rush of oncology drug news cooled down. Today was dominated by the “red screen” with profit taking mainly in smaller caps and momentum driven oncology stocks.
In this article: MRK, ALNY, ALXN, BMRN, INCY, CELG, CLVS, VRTX, ZIOP, JUNO, PBYI, EPZM, GLYC, KITE, TSRO
Read
ASCO Abstracts Week: Biotech Trends And Hot Stocks
Article By: Rod Raynovich
Monday, May 22, 2017 10:58 PM EDT
Today Amgen was down over 2 % on news that its osteoporosis treatment Evenity is unlikely to win FDA approval this year because of a safety risk. Radius Health was up over 6% to $37.30 as their rival drug Tymlos was approved in April.
In this article: MRK, ALNY, IBB, INCY, REGN, AMGN, CLVS, VRTX, FBT, XBI, PUMA, JUNO, EPZM, GLYC, KITE, BLUE, RDUS
Read

PARTNER HEADLINES

Latest Tweets for $EPZM

No tweets yet!